Literature DB >> 31076727

Peripheral memory T cells specific for Arginase-1.

Evelina Martinenaite1, Shamaila Munir Ahmad2, Inge Marie Svane2, Mads Hald Andersen3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31076727      PMCID： PMC6804944          DOI： 10.1038/s41423-019-0231-3

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  10 in total

1.  Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators.

Authors:  Rikke Baek Sørensen; Sine Reker Hadrup; Inge Marie Svane; Mads Christian Hjortsø; Per Thor Straten; Mads Hald Andersen
Journal:  Blood       Date:  2010-11-15       Impact factor: 22.113

2.  Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy.

Authors:  Mads Hald Andersen
Journal:  J Natl Cancer Inst       Date:  2015-06-10       Impact factor: 13.506

3.  Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer.

Authors:  Sunil Singhal; Jason Stadanlick; Michael J Annunziata; Abhishek S Rao; Pratik S Bhojnagarwala; Shaun O'Brien; Edmund K Moon; Edward Cantu; Gwenn Danet-Desnoyers; Hyun-Jeong Ra; Leslie Litzky; Tatiana Akimova; Ulf H Beier; Wayne W Hancock; Steven M Albelda; Evgeniy B Eruslanov
Journal:  Sci Transl Med       Date:  2019-02-13       Impact factor: 17.956

4.  Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes.

Authors:  Wong Yu; Ning Jiang; Peter J R Ebert; Brian A Kidd; Sabina Müller; Peder J Lund; Jeremy Juang; Keishi Adachi; Tiffany Tse; Michael E Birnbaum; Evan W Newell; Darrell M Wilson; Gijsbert M Grotenbreg; Salvatore Valitutti; Stephen R Quake; Mark M Davis
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

5.  Dual Transforming Growth Factor-β and Programmed Death-1 Blockade: A Strategy for Immune-Excluded Tumors?

Authors:  Claire Vanpouille-Box; Silvia C Formenti
Journal:  Trends Immunol       Date:  2018-03-26       Impact factor: 16.687

Review 6.  The Balance Players of the Adaptive Immune System.

Authors:  Mads Hald Andersen
Journal:  Cancer Res       Date:  2018-02-13       Impact factor: 12.701

7.  Frequent adaptive immune responses against arginase-1.

Authors:  Evelina Martinenaite; Rasmus Erik Johansson Mortensen; Morten Hansen; Morten Orebo Holmström; Shamaila Munir Ahmad; Nicolai Grønne Dahlager Jørgensen; Özcan Met; Marco Donia; Inge Marie Svane; Mads Hald Andersen
Journal:  Oncoimmunology       Date:  2017-12-26       Impact factor: 8.110

8.  HLA-restricted CTL that are specific for the immune checkpoint ligand PD-L1 occur with high frequency in cancer patients.

Authors:  Shamaila Munir; Gitte Holmen Andersen; Özcan Met; Marco Donia; Thomas Mørch Frøsig; Stine Kiaer Larsen; Tobias Wirenfeldt Klausen; Inge Marie Svane; Mads Hald Andersen
Journal:  Cancer Res       Date:  2013-01-17       Impact factor: 12.701

Review 9.  Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

Authors:  Ulrich Keilholz; Jeffrey Weber; James H Finke; Dmitry I Gabrilovich; W Martin Kast; Mary L Disis; John M Kirkwood; Carmen Scheibenbogen; Jeff Schlom; Vernon C Maino; H Kim Lyerly; Peter P Lee; Walter Storkus; Franceso Marincola; Alexandra Worobec; Michael B Atkins
Journal:  J Immunother       Date:  2002 Mar-Apr       Impact factor: 4.456

Review 10.  Targeting macrophages: therapeutic approaches in cancer.

Authors:  Luca Cassetta; Jeffrey W Pollard
Journal:  Nat Rev Drug Discov       Date:  2018-10-26       Impact factor: 84.694
  10 in total
  3 in total

1.  Anti-regulatory T cells are natural regulatory effector T cells.

Authors:  Niels Ødum
Journal:  Cell Stress       Date:  2019-10-08

Review 2.  Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression.

Authors:  Andreia Matos; Marcos Carvalho; Manuel Bicho; Ricardo Ribeiro
Journal:  Nutrients       Date:  2021-12-16       Impact factor: 5.717

3.  The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines.

Authors:  Stine Emilie Weis-Banke; Mie Linder Hübbe; Morten Orebo Holmström; Mia Aaboe Jørgensen; Simone Kloch Bendtsen; Evelina Martinenaite; Marco Carretta; Inge Marie Svane; Niels Ødum; Ayako Wakatsuki Pedersen; Özcan Met; Daniel Hargbøl Madsen; Mads Hald Andersen
Journal:  Oncoimmunology       Date:  2020-06-01       Impact factor: 8.110
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.